CS logo
small CS logo
Georgian Diabetes Center

Tbilisi, Georgia
PPCM+CM9, Tbilisi

About Georgian Diabetes Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
AtheroGenics
1
CymaBay Therapeutics, Inc.
1
Total Rows: 2

Clinical Trials at Georgian Diabetes Center


During the past decade, Georgian Diabetes Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study
2007-08-01
2008-09-01
Unknown status
1,012
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes
2009-12-01
2010-08-01
Completed
100

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsAtheroGenics: 1AtheroGenics: 1CymaBay Therapeutics, Inc.: 1CymaBay Therapeutics, Inc.: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Georgian Diabetes Center


According to Clinical.Site data, the most researched conditions in "Georgian Diabetes Center" are "Diabetes" (2 trials). Many other conditions were trialed in "Georgian Diabetes Center" in a lesser frequency.

Clinical Trials Intervention Types at Georgian Diabetes Center


Most popular intervention types in "Georgian Diabetes Center" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "AGI-1067" (1 trials), "MBX-2982" (1 trials), "Placebo" (1 trials), "Sitagliptin" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Georgian Diabetes Center


The vast majority of trials in "Georgian Diabetes Center" are 2 trials for "All" genders.

Clinical Trials Status at Georgian Diabetes Center


Currently, there are NaN active trials in "Georgian Diabetes Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Georgian Diabetes Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Georgian Diabetes Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 2Phase 2: 2Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 1Completed: 1Unknown status: 1Unknown status: 1